2021
Prevalence of adiposity-based chronic disease in middle-aged adults from Czech Republic: The Kardiovize study
GONZALEZ-RIVAS, J. P., J. I. MECHANICK, J. P. HERNANDEZ, M. M. INFANTE-GARCIA, Iuliia PAVLOVSKA et. al.Základní údaje
Originální název
Prevalence of adiposity-based chronic disease in middle-aged adults from Czech Republic: The Kardiovize study
Autoři
GONZALEZ-RIVAS, J. P. (garant), J. I. MECHANICK, J. P. HERNANDEZ, M. M. INFANTE-GARCIA, Iuliia PAVLOVSKA (804 Ukrajina, domácí), J. R. MEDINA-INOJOSA, Sarka KUNZOVA (203 Česká republika), R. NIETO-MARTINEZ, Jan BROZ (203 Česká republika), L. BUSETTO, G. A. M. NETO, F. LOPEZ-JIMENEZ, Jana URBANOVA (203 Česká republika) a G. B. STOKIN
Vydání
OBESITY SCIENCE & PRACTICE, HOBOKEN, WILEY, 2021, 2055-2238
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30202 Endocrinology and metabolism
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Kód RIV
RIV/00216224:14110/21:00121638
Organizační jednotka
Lékařská fakulta
UT WoS
000647238400001
Klíčová slova anglicky
adiposity; cardiovascular disease; epidemiology; obesity; overweight
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 7. 12. 2021 13:01, Mgr. Tereza Miškechová
Anotace
V originále
Aims/Hypothesis The need for understanding obesity as a chronic disease, its stigmatization, and the lack of actionability related to it demands a new approach. The adiposity-based chronic disease (ABCD) model is based on adiposity amount, distribution, and function, with a three stage complication-centric rather than a body mass index (BMI)-centric approach. The prevalence rates and associated risk factors are presented. Methods In total, 2159 participants were randomly selected from Czechia. ABCD was established as BMI >= 25 kg/m(2) or high body fat percent, or abdominal obesity and then categorized by their adiposity-based complications: Stage 0: none; Stage 1: mild/moderate; Stage 2: severe. Results ABCD prevalence was 62.8%. Stage 0 was 2.3%; Stage 1 was 31.4%; Stage 2 was 29.1%. Comparing with other classifiers, participants in Stage 2 were more likely to have diabetes, hypertension, and metabolic syndrome than those with overweight, obesity, abdominal obesity, and increased fat mass. ABCD showed the highest sensitivity and specificity to detect participants with peripheral artery disease, increased intima media, and vascular disease. Conclusion/Interpretation The ABCD model provides a more sensitive approach that facilitates the early detection and stratification of participants at risk compared to traditional classifiers.